T. Rowe Price Associates’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$71.3M Buy
1,113,956
+459,555
+70% +$30.2M 0.01% 783
2026
Q1
$46.6M Sell
654,401
-1,114,975
-63% -$87.9M 0.01% 789
2025
Q4
$145M Sell
1,769,376
-290,304
-14% -$22.6M 0.02% 549
2025
Q3
$155M Buy
2,059,680
+4,226
+0.2% +$315K 0.02% 517
2025
Q2
$152M Sell
2,055,454
-910,880
-31% -$63.4M 0.02% 489
2025
Q1
$239M Sell
2,966,334
-3,198,337
-52% -$275M 0.03% 387
2024
Q4
$482M Sell
6,164,671
-408,038
-6% -$34.7M 0.06% 274
2024
Q3
$617M Sell
6,572,709
-761,448
-10% -$63.9M 0.07% 244
2024
Q2
$571M Sell
7,334,157
-2,627,361
-26% -$214M 0.07% 247
2024
Q1
$906M Sell
9,961,518
-2,132,389
-18% -$177M 0.11% 176
2023
Q4
$935M Sell
12,093,907
-165,487
-1% -$11.6M 0.13% 162
2023
Q3
$834M Sell
12,259,394
-3,517,555
-22% -$256M 0.12% 175
2023
Q2
$1.28B Sell
15,776,949
-2,545,313
-14% -$203M 0.18% 114
2023
Q1
$1.5B Buy
18,322,262
+11,962,261
+188% +$854M 0.23% 94
2022
Q4
$371M Buy
+6,360,001
New +$366M 0.06% 280

Other funds holding GEHC

T. Rowe Price Associates's GEHC Position: Q2 2026 in Review

T. Rowe Price Associates increased its GE HealthCare (GEHC) stake by 70% in Q2 2026, buying an estimated $30.2M and bringing the position to 1,113,956 shares worth $71.3M. The position accounts for 0.01% of the portfolio, ranked #783.

T. Rowe Price Associates first reported a position in GEHC in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.5B in Q1 2023. 1,224 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • T. Rowe Price Associates held 1,113,956 shares of GE HealthCare worth $71.3M as of Q2 2026.
  • T. Rowe Price Associates bought 459,555 GE HealthCare shares in Q2 2026, an estimated $30.2M.
  • GE HealthCare made up 0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #783 holding.
  • T. Rowe Price Associates first reported a position in GE HealthCare in Q4 2022 and has held it in 15 quarters since.
  • T. Rowe Price Associates's GE HealthCare position peaked at $1.5B in Q1 2023.
  • 1,224 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.